<div><p>(A–D) Magnitude and breadth of increase of HIV-specific CD8+ T cells during supervised treatment interruptions.</p> <p>(A and B) Magnitude (A) and breadth (B) of HIV-specific CD8+ responses at the first day of treatment interruption (black bars) and at the last day off therapy (white bars). Data represent the mean and standard deviation.</p> <p>(C and D) Correlation between the increase of the magnitude (C) or breadth (D) of CD8+ T cell responses and the time off therapy during the first treatment interruption.</p> <p>(E and F) Evolution of CD4+ T helper cell responses during supervised treatment interruptions.</p> <p>(E) Magnitude of CD4 T helper cell responses at baseline and at the ...
<p>(A) Longitudinal analysis from baseline (same day as ART initiation) and 6 months post ART for to...
<p>(A) Percentage of CD45RA+/CCR7−/CD8+ T cells for the 126 and 106 HIV-1-specific CD8+ T cell respo...
<p>(A and B) Fresh CD8-depleted PBMCs from 12 adult individuals with documented primary HIV infectio...
OBJECTIVES: To analyze the dynamics of both HIV-1-specific CD4 and CD8 T-cell responses during struc...
OBJECTIVES: To analyze the dynamics of both HIV-1-specific CD4 and CD8 T-cell responses during struc...
<p><b>A.</b> Longitudinal analysis of the CD4 T-cell counts and HIV viremia of 2 representative HIV-...
<p>(A) Proportions of CD4 (upper plots) and CD8 (lower plots) T cells specific for the indicated HIV...
<p>a. Gating scheme used for the identification of CD8<sup>+</sup> T-cell responses. Data shown were...
<p>a. Correlation between the CD8<sup>+</sup> T-cell functionalities and blood CD4<sup>+</sup>T-cell...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
International audienceThe influence of HIV burden variations on the frequencies of Ag-specific CD8+ ...
<p><b>A.</b> Representative examples of functional avidity of HIV-specific CD8 T-cell responses in p...
<p>Antiviral CD8<sup>+</sup> T-cell capacity measured at 12-months post-infection versus percentage ...
Multiple lines of evidence indicate that CD8 + T cells are important in the control of HIV-1...
<p>(A) Evolutionary rate and CD4+ T-cell level as a function of time relative to seroconversion. Bas...
<p>(A) Longitudinal analysis from baseline (same day as ART initiation) and 6 months post ART for to...
<p>(A) Percentage of CD45RA+/CCR7−/CD8+ T cells for the 126 and 106 HIV-1-specific CD8+ T cell respo...
<p>(A and B) Fresh CD8-depleted PBMCs from 12 adult individuals with documented primary HIV infectio...
OBJECTIVES: To analyze the dynamics of both HIV-1-specific CD4 and CD8 T-cell responses during struc...
OBJECTIVES: To analyze the dynamics of both HIV-1-specific CD4 and CD8 T-cell responses during struc...
<p><b>A.</b> Longitudinal analysis of the CD4 T-cell counts and HIV viremia of 2 representative HIV-...
<p>(A) Proportions of CD4 (upper plots) and CD8 (lower plots) T cells specific for the indicated HIV...
<p>a. Gating scheme used for the identification of CD8<sup>+</sup> T-cell responses. Data shown were...
<p>a. Correlation between the CD8<sup>+</sup> T-cell functionalities and blood CD4<sup>+</sup>T-cell...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
International audienceThe influence of HIV burden variations on the frequencies of Ag-specific CD8+ ...
<p><b>A.</b> Representative examples of functional avidity of HIV-specific CD8 T-cell responses in p...
<p>Antiviral CD8<sup>+</sup> T-cell capacity measured at 12-months post-infection versus percentage ...
Multiple lines of evidence indicate that CD8 + T cells are important in the control of HIV-1...
<p>(A) Evolutionary rate and CD4+ T-cell level as a function of time relative to seroconversion. Bas...
<p>(A) Longitudinal analysis from baseline (same day as ART initiation) and 6 months post ART for to...
<p>(A) Percentage of CD45RA+/CCR7−/CD8+ T cells for the 126 and 106 HIV-1-specific CD8+ T cell respo...
<p>(A and B) Fresh CD8-depleted PBMCs from 12 adult individuals with documented primary HIV infectio...